#400 Antiplatelets, Anticoagulation for Coronary Artery Disease and Afib
The Curbsiders Internal Medicine Podcast
00:00
The Limitations of Aspirin for Primary Prevention
In 2018, we had three large, well-done trials that were all negative for aspirin for primary prevention. So how do you think about this patient? Are there exceptions to the aspirin for both and for patients for primary prevention? How are we thinking about these things these days? Yeah, so it's a wonderful question. And I think this is right where the the boundary condition is in a patient like Regina.
Transcript
Play full episode
